Pharmacokinetic study to compare itepekimab exposure when administered with an autoinjector versus prefilled syringe

Trial Identifier: PKM16966
Sponsor: Sanofi
Collaborator:
Regeneron Pharmaceuticals
Start Date: September 2021
Primary Completion Date: March 2022
Study Completion Date: March 2022
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
UNITED STATES, Florida Miami, Florida, UNITED STATES, 33014